AU2004275971B2 - Pyridylacetylenes for use as radiotracers and imaging agents - Google Patents

Pyridylacetylenes for use as radiotracers and imaging agents Download PDF

Info

Publication number
AU2004275971B2
AU2004275971B2 AU2004275971A AU2004275971A AU2004275971B2 AU 2004275971 B2 AU2004275971 B2 AU 2004275971B2 AU 2004275971 A AU2004275971 A AU 2004275971A AU 2004275971 A AU2004275971 A AU 2004275971A AU 2004275971 B2 AU2004275971 B2 AU 2004275971B2
Authority
AU
Australia
Prior art keywords
compound
formula
free base
acid addition
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004275971A
Other languages
English (en)
Other versions
AU2004275971A1 (en
Inventor
Simon Mensah Ametamey
Yves Auberson
Fabrizio Gasparini
Lea Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2004275971A1 publication Critical patent/AU2004275971A1/en
Application granted granted Critical
Publication of AU2004275971B2 publication Critical patent/AU2004275971B2/en
Priority to AU2008261192A priority Critical patent/AU2008261192B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2004275971A 2003-09-26 2004-09-24 Pyridylacetylenes for use as radiotracers and imaging agents Ceased AU2004275971B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008261192A AU2008261192B2 (en) 2003-09-26 2008-12-23 Pyridylacetylenes for use as radiotracers and imaging agents

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0322612.3 2003-09-26
GBGB0322612.3A GB0322612D0 (en) 2003-09-26 2003-09-26 Organic compounds
PCT/EP2004/010743 WO2005030723A1 (en) 2003-09-26 2004-09-24 Pyridylacetylenes for use as radiotracers and imaging agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008261192A Division AU2008261192B2 (en) 2003-09-26 2008-12-23 Pyridylacetylenes for use as radiotracers and imaging agents

Publications (2)

Publication Number Publication Date
AU2004275971A1 AU2004275971A1 (en) 2005-04-07
AU2004275971B2 true AU2004275971B2 (en) 2008-10-02

Family

ID=29286926

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2004275971A Ceased AU2004275971B2 (en) 2003-09-26 2004-09-24 Pyridylacetylenes for use as radiotracers and imaging agents
AU2008261192A Ceased AU2008261192B2 (en) 2003-09-26 2008-12-23 Pyridylacetylenes for use as radiotracers and imaging agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008261192A Ceased AU2008261192B2 (en) 2003-09-26 2008-12-23 Pyridylacetylenes for use as radiotracers and imaging agents

Country Status (13)

Country Link
US (2) US8674110B2 (https=)
EP (1) EP1670762B1 (https=)
JP (1) JP4965255B2 (https=)
CN (1) CN100430380C (https=)
AU (2) AU2004275971B2 (https=)
BR (1) BRPI0414732A (https=)
CA (1) CA2539469C (https=)
ES (1) ES2400713T3 (https=)
GB (1) GB0322612D0 (https=)
MX (1) MXPA06003424A (https=)
PL (1) PL1670762T3 (https=)
PT (1) PT1670762E (https=)
WO (1) WO2005030723A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
WO2011092290A1 (en) 2010-02-01 2011-08-04 Novartis Ag Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
EA023020B1 (ru) * 2010-07-09 2016-04-29 Рекордати Айерленд Лимитед Спирогетероциклические соединения и их применение в качестве антагонистов mglu5
AR086554A1 (es) 2011-05-27 2014-01-08 Novartis Ag Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina
JP2015525202A (ja) 2012-05-03 2015-09-03 ノバルティス アーゲー グレリン受容体アゴニストとしての２，７−ジアザ−スピロ［４，５］デカ−７−イル誘導体のｌ−リンゴ酸塩およびその結晶形態

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6843979B2 (en) 1999-04-26 2005-01-18 Emory University 4-haloethenylphenyl tropane:serotonin transporter imaging agents
EP1048302A3 (en) 1999-04-30 2002-07-17 Pfizer Products Inc. Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease
WO2001001621A2 (en) * 1999-06-30 2001-01-04 Sun Microsystems, Inc. Customizing web content based on network conditions
EP1214303A1 (en) * 1999-08-31 2002-06-19 Merck & Co., Inc. Heterocyclic compounds and methods of use thereof
GB0103045D0 (en) * 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
JP4070431B2 (ja) 2001-07-10 2008-04-02 ジーイー・ヘルスケア・リミテッド モノアミン再取込み部位のマッピング用ヨウ素付加神経プローブ
WO2004038374A2 (en) 2002-10-24 2004-05-06 Merck & Co., Inc. Alkyne derivatives as tracers for metabotropic glutamate receptor binding

Also Published As

Publication number Publication date
MXPA06003424A (es) 2006-06-20
CA2539469A1 (en) 2005-04-07
CN100430380C (zh) 2008-11-05
AU2008261192B2 (en) 2011-08-04
BRPI0414732A (pt) 2006-11-21
PL1670762T3 (pl) 2013-05-31
AU2008261192A1 (en) 2009-01-22
ES2400713T3 (es) 2013-04-11
CN1856468A (zh) 2006-11-01
EP1670762B1 (en) 2012-12-05
US20140142318A1 (en) 2014-05-22
JP2007506698A (ja) 2007-03-22
JP4965255B2 (ja) 2012-07-04
CA2539469C (en) 2012-06-19
WO2005030723A1 (en) 2005-04-07
EP1670762A1 (en) 2006-06-21
US8674110B2 (en) 2014-03-18
PT1670762E (pt) 2013-02-07
AU2004275971A1 (en) 2005-04-07
US20090010838A1 (en) 2009-01-08
GB0322612D0 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
AU2008261192B2 (en) Pyridylacetylenes for use as radiotracers and imaging agents
IL139127A (en) Process for the synthesis of COX-2 inhibitors and an intermediate of these inhibitors
JPS60112793A (ja) ６―ビニル―フロー（３，４―ｃ）―ピリジン誘導体，その製造法及びそれを含有する利尿組成物
CS264295B2 (en) Process for preparing derivatives of 2-brom-alpha-ergo-cryptine
JPS6163671A (ja) ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
PT91326A (pt) Processo para a preparacao de derivados de imidazo-{4,5-b}piridina
US20090156801A1 (en) Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
Kozaka et al. Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT)
Mátyus et al. Novel pyridazino [4, 5-b][1, 5] oxazepines and-thiazepines as 5-HT1A receptor ligands
IE883136L (en) Ó(2)-adreno receptor antagonists
EP0966440B1 (en) Method of production and method of separation of 2,4'-dipyridyl derivatives and methods of production of benzoxazepine derivatives and salts thereof
NO812401L (no) Nye halogenfenyl-pyridyl-allylaminderivater.
Harmata et al. A general, regioselective approach to the synthesis of ortho allylanilines
CN113307758A (zh) 一种医用放射性同位素标记的p2x7受体靶向探针前体
Nakamura et al. Simple and efficient preparation of sterically protected 1, 4-diphosphafulvenes
WO2006107106A1 (ja) 小胞アセチルコリントランスポーターに対するリガンド
Kawano et al. Synthesis of oligo (2-ethynylpyridines): novel building blocks for supramolecular systems
CN113583012B (zh) 一种吡喃并[4,3-b]吡啶-2,7-二酮化合物的合成方法
JP4212123B2 (ja) ２，４′―ジピリジル誘導体の製造方法、分離方法並びにベンゾオキサゼピン誘導体およびその塩の製造方法
Gielow et al. Synthesis and preliminary biological evaluation of [123I] Me2Pyr, a new potential ligand for imaging of central cannabinoid CB1 receptors
Landesberg et al. Addition of N-bromosuccinimide to 3-sulfolene
Sutter et al. The specificity of reductive dechlorination in the polychloropyridine series. Synthesis of 2, 3, 5‐trichloro‐and of 2, 3, 5, 6‐tetrachloropyridine
JPH0395138A (ja) ３―メチルヘプタン酸の光学分割法
JPS6216462A (ja) ４−シアノピペリジン誘導体
JPS6134428B2 (https=)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired